The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
OXALIPLATIN. Fibrin degradation products increased 1
OXALIPLATIN. Focal nodular hyperplasia 1
OXALIPLATIN. Formication 1
OXALIPLATIN. Gastric haemorrhage 1
OXALIPLATIN. Gastric perforation 1
OXALIPLATIN. Gastrointestinal necrosis 1
OXALIPLATIN. Gastrointestinal perforation 1
OXALIPLATIN. Generalised oedema 1
OXALIPLATIN. Grip strength decreased 1
OXALIPLATIN. Haematemesis 1
OXALIPLATIN. Haemodynamic instability 1
OXALIPLATIN. Haemolysis 1
OXALIPLATIN. Hepatic calcification 1
OXALIPLATIN. Hepatic cirrhosis 1
OXALIPLATIN. Hepatic enzyme increased 1
OXALIPLATIN. Hepatic neoplasm 1
OXALIPLATIN. Hepatic steatosis 1
OXALIPLATIN. Hepatitis 1
OXALIPLATIN. Hepatitis acute 1
OXALIPLATIN. Hepatitis toxic 1

Total Records: 864     Number of Pages: 44